LATEST NEWS
Strategic partnership: Cannava + Fitosil
We held a bilateral meeting with the Fitosil team to take forward the development of an operational and commercial agreement. This joint initiative represents the synergy of our capabilities and visions to boost the supply and marketing of pharmaceutical-grade cannabis-derived products throughout the region.
.jpeg)
Cannava took part in Cannabis Europe 2026 in London
Cannava took part in Cannabis Europe 2026 in London, one of the leading international events in the medical cannabis industry, which brought together business leaders, investors, regulators and key figures from the sector across Europe and the Americas.
Visit by ANVISA officials to Cannava
We welcomed Brazil’s National Health Surveillance Agency (ANVISA) for a day of technical and institutional exchange.
This meeting is part of the regulatory update process that Brazil is spearheading regarding the production, marketing, and importation of cannabis-derived products, and it opens up new opportunities for regional coordination.
Strengthening Argentina's presence in the European market
We are proud to announce the renewal of our strategic supply agreement with NOC PHARMA, a key player in the distribution of medical cannabis in Germany.
Cannava reaches a market valuation that almost triples the initial public investment and sparks interest from international companies
As part of the management report presented by outgoing president Gastón Morales, CANNAVA SE presented its management report to the Provincial General Audit Office and subsequently to provincial media, along with company authorities.
Cannava in the COFA magazine
We share the note made by the College of Pharmacists about the study of new formulations with medicinal cannabis made by our company.
![20260616_110845[1].jpg.jpeg](https://static.wixstatic.com/media/9ea287_c2af7c67104d485aa6fb38406fae4556~mv2.jpeg/v1/crop/x_0,y_369,w_4000,h_2263/fill/w_297,h_168,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/20260616_110845%5B1%5D_jpg.jpeg)
Strategic partnership: Cannava + UNJu
We have signed a cooperation agreement with the National University of Jujuy (UNJu) to promote research, development and technological innovation in the region.
.jpeg)
Joint growth and trust: our partnership with Noc Pharma
At Cannava, we are committed to leading the way in the production of medical cannabis to the highest international standards. Achieving this on a global scale requires not only our own efforts, but also the building of strong, mutually trusting relationships with strategic partners who share our vision.
Jujuy is promoting energy innovation to boost its economic development
The Province of Jujuy signed a cooperation agreement with Gotion as part of its strategy to strengthen industrial competitiveness and optimize energy use.
Cannava renews its international GACP certification: excellence guaranteed from cultivation
Cannava proudly announces the renewal of its GACP (Good Agricultural and Collection Practice) certification, consolidating its position as a benchmark in the production of pharmaceutical-grade medicinal cannabis in the region.
.jpg)
Cannava in Psychopharmacology
One of the most recognized international scientific journals in the field of neuropsychopharmacology published the results of an investigation carried out with pharmaceutical products developed entirely in Cannava.
Cannava Quality Lab
We provide cannabinoid profile study services for pharmaceutical/cosmetic laboratories and projects authorized by the Ministry of Health.
.jpeg)
Strategic partnership: Cannava + UBA
We have signed a technical assistance and training agreement with the Faculty of Medicine at the University of Buenos Aires (UBA).
New agreement with Noc Pharma: we will export medical cannabis granules
We are proud to announce the signing of a new strategic commercial agreement with NOC PHARMA, a key player in the distribution of medical cannabis in Germany
Cannava goes global: Strategic mission to China
Led by our president, Ignacio Bruera, we participated in an institutional mission to the People's Republic of China to strengthen ties with key players in the pharmaceutical sector, such as the BBCA Group.
Cannava in the Farmespaña Industrial magazine about cannabis for chronic pain
The prestigious magazine Farmespaña Industrial has highlighted in its latest special edition the DOLOCANN clinical trial, led by CANNAVA SE.
.jpg)
Jujuy already exports pharmaceutical-grade cannabis flowers to Portugal, Germany, and Australia.
In a period of remarkable growth and expansion, CANNAVA, the leading state-owned company in the production of pharmaceutical-grade medicinal cannabis in Argentina, has achieved significant milestones that consolidate its position in the global market.
Cannabis in Brazil
We have begun the process of registering our products with ANVISA .
This strategic step reflects our vision of growth, sustainability and innovation, reaffirming our leadership in Argentina and South America.